Other
2023 Subject Index
J Turk Acad Dermatol 2023;17(4):0-0
| Acne | 10 |
| Adnexal tumors | 76 |
| Alcohol consumption | 92 |
| Alopecia areata | 62 |
| Androgenetic alopecia | 69 |
| Anti-aging | 37 |
| Antifungal | 83 |
| Atopic dermatitis | 18 |
| Azathioprine | 41 |
| Balanitis | 1 |
| Bioelectrical impedance | 69 |
| Biologic agents | 80, 92 |
| Biological agents | 97 |
| Body mass index | 50 |
| Bullous | 27 |
| Bullous lesion | 103 |
| Bullous pemphigoid | 41 |
| Bullous skin disorders | 41 |
| Ceruloplasmin | 22 |
| CIMT | 69 |
| Clinicopathologic correlation | 76 |
| Collagen | 37 |
| Comorbidity | 92 |
| Conventional treatments | 92 |
| COVID-19 | 27 |
| COVID-19 vaccine | 35 |
| Dermatology | 80, 92 |
| Dermatology Quality of Life Index | 87, 106 |
| Dermoscopy | 54 |
| DLQI | 87, 106 |
| Dyspareunia | 1 |
| Dysuria | 1 |
| EFT | 69 |
| Facial erythema | 10 |
| Fissures | 1 |
| Genital | 1 |
| Geriatric | 92 |
| Hair follicle | 76 |
| Hemorrhagic blister | 103 |
| Herpes zoster | 35 |
| Hidradenitis suppurativa | 50 |
| Histopathology | 54 |
| Hurley stage | 50 |
| Immunohistochemistry | 54 |
| Immunosuppressant | 59 |
| Inflammation | 92 |
| Internet | 62 |
| Lentigo | 80 |
| Low dose | 18 |
| LTBI | 97 |
| Lupus erythematosus | 10 |
| mRNA vaccine | 35 |
| Nail | 46 |
| Nail psoriasis | 92 |
| Nevus sebaceus | 31 |
| New | 27 |
| Onset | 27 |
| Onychomycosis | 22, 46 |
| Oral mucosa | 103 |
| Oxidative stress | 22 |
| Pemphigoid | 27 |
| Pemphigus vulgaris | 41 |
| Phototherapy | 18, 87, 106 |
| Pilomatricoma | 76 |
| Premalignant | 1 |
| Psoriasis | 35, 80, 92, 97 |
| Psoriatic arthritis | 92 |
| Pustular psoriasis | 59 |
| Q-switched Nd:YAG laser | 46 |
| Quantiferon | 97 |
| Red face | 10 |
| Rosacea | 10 |
| Sebaceous | 76 |
| Secukinumab | 80 |
| Smoking | 50, 92 |
| Social media | 62 |
| Squamous cell carcinoma | 1 |
| Sudden onset | 103 |
| Superficial fungal infections | 83 |
| Supplementation | 37 |
| Sweat gland | 76 |
| Telangiectasia macularis eruptiva perstans | 54 |
| Temporal triangular alopecia | 31 |
| Treatment | 59, 83 |
| Trichoscopy | 31 |
| Tuberculosis | 97 |
| UVA-1 | 18 |
| Vaccine | 27 |
| Visceral fat | 69 |
| Vulvar dermatosis | 1 |
| Vulvar disease | 1 |
| VZV | 35 |
| Zona | 35 |